Mark K. White - 12 Oct 2021 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Mark White
Issuer symbol
ANVS
Transactions as of
12 Oct 2021
Net transactions value
+$137,000
Form type
4
Filing time
13 Oct 2021, 16:02:04 UTC
Previous filing
09 Jul 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Purchase $137,000 +5,000 +9.8% $27.40 56,177 12 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.25 to $27.55, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.